Drug intelligence / Profile preview

Santemin

Development stage: Unknown
Lead developer: Makshi Healthcare
Modality: Small Molecules
Administration: Oral

Overview

Santemin is a commercial multivitamin, multimineral, and amino acid syrup marketed by Makshi Healthcare. It is formulated to support overall metabolism, boost immunity, combat fatigue, stress, and general debility, and support healthy vascular and cardiac function. The syrup contains a combination of lysine hydrochloride, B-complex vitamins (B1, B2, B3, B5, B6, B12), vitamins A, D3, and E, along with essential minerals including zinc, copper, iodine, and others. It is indicated for nutritional deficiencies, loss of appetite, convalescence, and general weakness.

Brand names: Santemin
Other names: Santemin Syrup

Beyond the preview

Go deeper on Santemin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Santemin.

Explore the full profile